We recently hosted our 2nd Innovation Salon. This time our dinner party debated the utility of modern diagnostics: When are diagnostics most valuable for improving quality of care? When are diagnostics cost-effective? And what is the value to the healthcare system in the evolving industry for "personalized medicine"?

It was another great evening with a very lively discussion. Below we share the first two of our latest series of salon video interviews. They were conducted by our very talented colleague, Amy Ziari, of the Bateman Group.

First up is Adam Bosworth. Late of Google Health, BEA and Microsoft, Bosworth is now the founder and CEO of KEAS, a consumer health and wellness platform -- about which you will soon be hearing much more. Here's what Adam has to say about the role diagnostics will play in the transformation of healthcare:

Next up is Greg Went, founder and CEO of Adamas Pharmaceuticals, which is presently focused on developing diagnostics to cost-effectively address pandemic and seasonal influenza...

"One of the neat things about healthspottr is you bring together a fairly diverse group of people, with very different perspectives on diagnostics -- from a patient perspective, to a healthcare system perspective, to a scientific perspective and a medical perspective, " Went says. "There are folks who know a tremendous amount about it from a physician's standpoint, but have no idea about the economic realities underlying it. So it was a very good discussion."